REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Drbest Pharmaceuticals Private Limited (India)

Main Activities: All Other Chemical Product and Preparation Manufacturing
Full name: Drbest Pharmaceuticals Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Drbest Pharmaceuticals Private Limited is an unlisted company, incorporated on 15/01/2016. It has its registered office in the State of Chandigarh, India. Company's corporate identification number (CIN) is U24297CH2016PTC035895 and registration number is 035895. The company is a trade company, it is engaged in wholesale trading, retail trading.

Legal Address
Plot No.157-A, Ground Floor Periphery Road, Sarangpur
Chandigarh; Punjab; Postal Code: 160014

Contact Details: Purchase the Drbest Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Drbest Pharmaceuticals Private Limited report to view the information.
Outstanding Shares:
Purchase the Drbest Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Drbest Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
January 15, 2016
Key Executives
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Drbest Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-12.31%▼
Total operating revenue
-12.65%▼
Operating profit (EBIT)
-91.86%▼
EBITDA
-55.28%▼
Net Profit (Loss) for the Period
-75.46%▼
Total assets
-21.94%▼
Total equity
1%▲
Operating Profit Margin (ROS)
-1.25%▼
Net Profit Margin
-0.84%▼
Return on Equity (ROE)
-4.06%▼
Debt to Equity Ratio
-45.1%▼
Quick Ratio
0.17%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo